Stuart Mitchell, Novuson Surgical - Studio Interview | LSI USA '25

Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications.

LSI USA ‘26 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

March 16th - 20th, 2026  Waldorf Astoria, Monarch Beach Register arrow